Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities

Research


Please find all related articles below.



MEPs raise concerns about sale of human eggs for fertility treatment


A group of MEPs, including Mrs Hiltrud Breyer MEP (Greens/EFA - DE), Mr Peter Liese MEP (EPP/ED - DE), Mr Adamos Adamou MEP (GUE/NGL - CY) and Ms Maria Martens MEP (EPP/ED - NL), have raised concerns about media reports of a trade of human egg cells from Romania to clinics in the UK. In many European countries there are shortages of donated eggs and long waiting lists for fertility treatment. The news report that young Romanian women are being paid to donate their eggs led the UK (...)
03/05/2005

Bioethics at stake in the new FP7


The European Commission encounters a sound opposition from the European Parliament to introducing European funding for research on human embryo and embryonic stem cells in the next 7th Research Framework Programme (FP7). On the 20 September 2005, a group of 73 MEPs have signed a letter to the European Commission President, Manuel Barroso, calling the Commission to respect the principle of subsidiarity in the matter: Member States should decide if they want to fund research on the human (...)
Also about: Biotechnology
03/05/2005

New tool for scientific input into policy-making


The Commission has launched a new e-Network designed to make scientific advice more available to policy-makers at the EU and national level called SINAPSE (Scientific Information for Policy Support in Europe). The new web-platform is to promote and encourage exchange of information between policy-makers and the scientific community. It will aim to be: A library of scientific opinion and advice A tool for the Commission to consult the scientific community An early-warning system A (...)
Also about:
19/04/2005

Health Action International on European medicines’ policy


Health Action International-Europe (HAI), an EPHA member, has recently published three new position papers on key issues affecting European medicines’ policy. "Running on empty: Medicines’ production and the absence of innovation" lays out HAI’s view that the pharmaceutical industry does not and will not produce medicines geared to public need - i.e. geared to priority conditions, at affordable prices and of genuine therapeutic advance. It concludes by urging (...)
14/03/2005

Petition to WHO on research and development of medicines


On 24 February 2005, 162 non-governmental organisations, academics and politicians issued an open letter urging the World Health Organisation to evaluate the draft Medical Research and Development Treaty that has been drawn up over the past two years by a group of economists, scientists and public health experts Existing trade agreements designed to bolster medical R&D investments focus nearly exclusively on stronger intellectual property rights and higher drug prices. This approach (...)
02/03/2005

EU scientists find no link between parabens and breast cancer


Parabens are a group of chemicals widely used as preservatives in food products, medicines and cosmetics such as lipsticks and deodorants. The Cosmetic Directive of 1976 sets the maximum concentration for their use in cosmetic products. Since then, a number of scientific publications have suggested a link between breast cancer and the use of paraben-containing deodorants and antiperspirants. DG SANCO requested an opinion from the Scientific Committee on Consumer Products (SCCP) . The (...)
21/02/2005

Third Ministerial Conference on eHealth


eHealth is the use of information technologies, especially the Internet, to enhance the quality and accessibility of health services. Applications range from simple administrative tools such as managing patient databases to complex clinical applications which can support the clinician in diagnosis and treatment. As part of an overall approach to increasing the uptake of new technologies, the European Commission has managed an eHealth programme for several years. The third Ministerial (...)
Also about: Healthcare services
21/02/2005

New Call for Proposals for EU funding on Emerging Science and Technology


The European Commission’ s DG Research has launched a call for proposals under the budgetline New and Emerging Science and Technology (NEST). The deadline for application is April 13 2005. INSIGHT projects INSIGHT projects must demonstrate an anticipatory function. They are scientific investigations designed to provide identification and clarification of discoveries and phenomena that could lead to potential risks for the society. They should aim at developing scientific (...)
Also about: EU Institutions
22/01/2005

Exploring the future of ’Science Shops’


The European Commission hosted a conference to review the successes of a network of Science Shops and explored opportunities to enlarge the network of partners. The EPHA Secretariat attended the meeting organised by the DG Research together with representatives from NGO’s, Universities and existing Science Shops from throughout Europe. Science shops are organisations created as mediators between citizen groups (trade unions, pressure groups, non-profit organisations, social groups, (...)
Also about: Civil Society
03/12/2004

Regional view on health from Finland


A number of European regional representatives, EU officials and met in Brussels to discuss how regional authorities could address health issues. Key health determinants were addressed at the conference which highlighted the results of the "Health Kuopio" project: healthy ageing, food and nutrition, pharmaceuticals, environment and e-Health. The Finnish region of Kuopio is developing a science park in cooperation with the University of Kuopio and the private sector. This partnership is (...)
01/12/2004